Highlights from a CLL session: BTKis, personalizing care, novel regimens, & more VJHemOnc – Video Journal of Hematology & HemOnc 3:17 2 months ago 66 Далее Скачать
Key highlights in CLL: clinical trial updates & the role of combination therapies and novel BTKis VJHemOnc – Video Journal of Hematology & HemOnc 6:43 1 year ago 1 412 Далее Скачать
Key updates and changes to the ESMO clinical practice guidelines for CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:29 6 days ago 46 Далее Скачать
BTK and BCL2 inhibitor resistance in CLL: session highlights VJHemOnc – Video Journal of Hematology & HemOnc 3:12 2 years ago 132 Далее Скачать
Customizing Care in CLL With BTK Inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 4:44 3 years ago 246 Далее Скачать
The potential of triplet regimens combining BTKis with venetoclax and obinutuzumab in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:25 1 month ago 61 Далее Скачать
Highlights from the lymphoma and CLL session VJHemOnc – Video Journal of Hematology & HemOnc 2:53 2 years ago 174 Далее Скачать
Customizing CLL care with BTK Inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 2:37 2 years ago 83 Далее Скачать
Pushing Boundaries in CLL: Targeted Therapy, Novel Combinations, and Precision Medicine PeerView Oncology 1:29:34 3 years ago 792 Далее Скачать
Treating R/R CLL: the value of BTKis and venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 1:59 1 month ago 103 Далее Скачать
Monitoring patients with CLL on ibrutinib-based therapies VJHemOnc – Video Journal of Hematology & HemOnc 1:13 2 months ago 45 Далее Скачать
Insights into the role of novel BTKis in the treatment landscape of R/R CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:49 4 months ago 80 Далее Скачать
Highlights from BSH: genetic profiling in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:31 2 years ago 107 Далее Скачать
Finite therapies with the combination of BTKis and venetoclax in CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:27 5 months ago 101 Далее Скачать
Novel options for patients with CLL who relapse after treatment with BTK inhibitors and venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 1:52 1 year ago 416 Далее Скачать
CLL treatment: a look into the future VJHemOnc – Video Journal of Hematology & HemOnc 1:19 2 years ago 321 Далее Скачать
Outcomes of Ven-based regimens in CLL/SLL following intolerance or progression on covalent BTKi's VJHemOnc – Video Journal of Hematology & HemOnc 2:26 11 months ago 359 Далее Скачать
Updates in CLL from EHA 2024: combinations of BTK and BCL2 inhibitors, BTK degraders, and more VJHemOnc – Video Journal of Hematology & HemOnc 11:55 5 months ago 604 Далее Скачать
The current role of continuous BTK inhibitors in CLL treatment: benefits and drawbacks VJHemOnc – Video Journal of Hematology & HemOnc 3:35 1 year ago 333 Далее Скачать
Continuous BTKi therapy in CLL: are time-limited combination therapies more beneficial? VJHemOnc – Video Journal of Hematology & HemOnc 2:56 2 months ago 138 Далее Скачать
